title: [Myocardial infarction in a patient free of coronary artery disease].
abstract: Triptans are widely used for treating migraine attacks. Their mechanism of action is attributable to cerebrovascular vasoconstriction. Vasoconstriction can occur also in the coronary arteries. Mild chest symptoms not related to myocardial ischemia have been reported among triptan users. Severe cardiovascular events have also been reported, but they are extremely rare. There are few observational studies focusing on the cardiovascular risks of triptans. Triptans are nevertheless considered contra-indicated in patients with coronary artery disease. We report a case of zolmitriptan-induced myocardial infarction in a patient free of coronary artery disease.
authors.forename: Kaj
authors.initials: K
authors.lastname: Ekström
authors.forename: Annika
authors.initials: A
authors.lastname: Lönnberg
authors.forename: Olli
authors.initials: O
authors.lastname: Anttonen
mesh_terms: D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced*; D023303:Oxazolidinones / Q000009:adverse effects*; D058825:Serotonin 5-HT1 Receptor Agonists / Q000009:adverse effects; D014363:Tryptamines / Q000009:adverse effects*
chemical_list: D023303:Oxazolidinones; D058825:Serotonin 5-HT1 Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan